{
    "2019-07-03": [
        [
            {
                "time": "2019-07-15",
                "original_text": "渝股点金｜智飞生物半年业绩预增55%-85% 建议继续持股",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩预增",
                        "继续持股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-16",
                "original_text": "智飞生物预计2019上半年净利超10亿元 筹备自研结核类产品上市",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "净利",
                        "自研产品",
                        "结核类"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-17",
                "original_text": "智飞生物：关注重磅产品审评进度 维持“买入”评级",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重磅产品",
                        "审评进度",
                        "买入评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-18",
                "original_text": "智飞生物：预防微卡获批在即 买入评级",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "预防微卡",
                        "获批在即",
                        "买入评级"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-01",
                "original_text": "智飞生物2019年上半年净利12.62亿 比上年同期上升85%",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "净利",
                        "同比上升"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-02",
                "original_text": "智飞生物:19H1业绩延续高增长 预防微卡获批在即",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩高增长",
                        "预防微卡",
                        "获批在即"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}